Knowing the incidence of invasive meningococcal disease (IMD) is essential for planning appropriate vaccination policies. However, IMD may be underestimated because of misdiagnosis or insufficiently sensitive laboratory methods. Using a national molecular surveillance register, we assessed the number of cases misdiagnosed and diagnoses obtained postmortem with real-time PCR (rPCR), and we compared sensitivity of rPCR versus culture-based testing. A total of 222 IMD cases were identified: 11 (42%) of 26 fatal cases had been misdiagnosed or undiagnosed and were reclassified as IMD after rPCR showed meningococcal DNA in all available specimens taken postmortem. Of the samples tested with both rPCR and culture, 58% were diagnosed by using rPCR alone. The underestimation factor associated with the use of culture alone was 3.28. In countries such as Italy, where rPCR is in limited use, IMD incidence may be largely underestimated; thus, assessments of benefits of meningococcal vaccination may be prone to error.

Underestimation of invasive meningococcal disease in Italy / Azzari, Chiara; Nieddu, Francesco; Moriondo, Maria; Indolfi, Giuseppe; Canessa, Clementina; Ricci, Silvia; Bianchi, Leila; Serranti, Daniele; Poggi, Giovanni Maria; Resti, Massimo. - In: EMERGING INFECTIOUS DISEASES. - ISSN 1080-6040. - ELETTRONICO. - 22:(2016), pp. 469-475. [10.3201/eid2203.150928]

Underestimation of invasive meningococcal disease in Italy

AZZARI, CHIARA;NIEDDU, FRANCESCO;MORIONDO, MARIA;INDOLFI, GIUSEPPE;RICCI, SILVIA;BIANCHI, LEILA;SERRANTI, DANIELE;POGGI, GIOVANNI MARIA;RESTI, MASSIMO
2016

Abstract

Knowing the incidence of invasive meningococcal disease (IMD) is essential for planning appropriate vaccination policies. However, IMD may be underestimated because of misdiagnosis or insufficiently sensitive laboratory methods. Using a national molecular surveillance register, we assessed the number of cases misdiagnosed and diagnoses obtained postmortem with real-time PCR (rPCR), and we compared sensitivity of rPCR versus culture-based testing. A total of 222 IMD cases were identified: 11 (42%) of 26 fatal cases had been misdiagnosed or undiagnosed and were reclassified as IMD after rPCR showed meningococcal DNA in all available specimens taken postmortem. Of the samples tested with both rPCR and culture, 58% were diagnosed by using rPCR alone. The underestimation factor associated with the use of culture alone was 3.28. In countries such as Italy, where rPCR is in limited use, IMD incidence may be largely underestimated; thus, assessments of benefits of meningococcal vaccination may be prone to error.
2016
22
469
475
Azzari, Chiara; Nieddu, Francesco; Moriondo, Maria; Indolfi, Giuseppe; Canessa, Clementina; Ricci, Silvia; Bianchi, Leila; Serranti, Daniele; Poggi, Giovanni Maria; Resti, Massimo
File in questo prodotto:
File Dimensione Formato  
Azzari Emerg Infect Dis. 2016.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 519.68 kB
Formato Adobe PDF
519.68 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1097771
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 29
social impact